Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.

Lifson JD, Rossio JL, Piatak M Jr, Bess J Jr, Chertova E, Schneider DK, Coalter VJ, Poore B, Kiser RF, Imming RJ, Scarzello AJ, Henderson LE, Alvord WG, Hirsch VM, Benveniste RE, Arthur LO.

AIDS Res Hum Retroviruses. 2004 Jul;20(7):772-87.

PMID:
15307924
2.

Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.

Mossman SP, Pierce CC, Watson AJ, Robertson MN, Montefiori DC, Kuller L, Richardson BA, Bradshaw JD, Munn RJ, Hu SL, Greenberg PD, Benveniste RE, Haigwood NL.

AIDS Res Hum Retroviruses. 2004 Apr;20(4):425-34.

PMID:
15157361
3.

Novel member of the CD209 (DC-SIGN) gene family in primates.

Bashirova AA, Wu L, Cheng J, Martin TD, Martin MP, Benveniste RE, Lifson JD, KewalRamani VN, Hughes A, Carrington M.

J Virol. 2003 Jan;77(1):217-27.

4.

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.

Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO.

J Virol. 2002 Jun;76(11):5315-25.

5.

Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.

Gorelick RJ, Benveniste RE, Lifson JD, Yovandich JL, Morton WR, Kuller L, Flynn BM, Fisher BA, Rossio JL, Piatak M Jr, Bess JW Jr, Henderson LE, Arthur LO.

J Virol. 2000 Dec;74(24):11935-49.

6.

Mucosal challenge of Macaca nemestrina with simian immunodeficiency virus (SIV) following SIV nucleocapsid mutant DNA vaccination.

Gorelick RJ, Lifson JD, Yovandich JL, Rossio JL, Piatak M Jr, Scarzello AJ, Knott WB, Bess JW Jr, Fisher BA, Flynn BM, Henderson LE, Arthur LO, Benveniste RE.

J Med Primatol. 2000 Aug;29(3-4):209-19.

PMID:
11085583
7.

Immunization against SIVmne in macaques using multigenic DNA vaccines.

Mossman SP, Pierce CC, Robertson MN, Watson AJ, Montefiori DC, Rabin M, Kuller L, Thompson J, Lynch JB, Morton WR, Benveniste RE, Munn R, Hu SL, Greenberg P, Haigwood NL.

J Med Primatol. 1999 Aug-Oct;28(4-5):206-13.

PMID:
10593487
8.

Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.

Polacino PS, Stallard V, Klaniecki JE, Pennathur S, Montefiori DC, Langlois AJ, Richardson BA, Morton WR, Benveniste RE, Hu SL.

J Virol. 1999 Oct;73(10):8201-15.

9.

Protection from pathogenic SIV challenge using multigenic DNA vaccines.

Haigwood NL, Pierce CC, Robertson MN, Watson AJ, Montefiori DC, Rabin M, Lynch JB, Kuller L, Thompson J, Morton WR, Benveniste RE, Hu SL, Greenberg P, Mossman SP.

Immunol Lett. 1999 Mar;66(1-3):183-8.

PMID:
10203053
10.

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines.

Polacino P, Stallard V, Montefiori DC, Brown CR, Richardson BA, Morton WR, Benveniste RE, Hu SL.

J Virol. 1999 Apr;73(4):3134-46.

11.

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.

Gorelick RJ, Benveniste RE, Gagliardi TD, Wiltrout TA, Busch LK, Bosche WJ, Coren LV, Lifson JD, Bradley PJ, Henderson LE, Arthur LO.

Virology. 1999 Jan 20;253(2):259-70.

12.

Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.

Polacino P, Stallard V, Klaniecki JE, Montefiori DC, Langlois AJ, Richardson BA, Overbaugh J, Morton WR, Benveniste RE, Hu SL.

J Virol. 1999 Jan;73(1):618-30.

13.

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

Arthur LO, Bess JW Jr, Chertova EN, Rossio JL, Esser MT, Benveniste RE, Henderson LE, Lifson JD.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S311-9.

PMID:
9814959
14.

Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations.

Heidecker G, Muñoz H, Lloyd P, Hodge D, Ruscetti FW, Morton WR, Hu S, Benveniste RE.

Virology. 1998 Sep 30;249(2):260-74.

15.

Sequence diversity of SIV(Mne) Nef in vivo and in vitro.

Heidecker G, Muñoz H, Lloyd PA, Hodge DR, Pei GK, Rick SW, Brehm K, Ruscetti FW, Kuller L, Polacino P, Hu SL, Morton WR, Benveniste RE.

J Med Primatol. 1998 Apr-Jun;27(2-3):73-80.

PMID:
9747946
17.

Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus.

Alpers CE, Tsai CC, Hudkins KL, Cui Y, Kuller L, Benveniste RE, Ward JM, Morton WR.

AIDS Res Hum Retroviruses. 1997 Mar 20;13(5):413-24.

PMID:
9075483
18.

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection.

Hu SL, Polacino P, Stallard V, Klaniecki J, Pennathur S, Travis BM, Misher L, Kornas H, Langlois AJ, Morton WR, Benveniste RE.

Immunol Lett. 1996 Jun;51(1-2):115-9.

PMID:
8811354
19.

Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver.

Ward JM, Benveniste RE, Fox CH, Battles JK, Gonda MA, Tully JG.

Am J Pathol. 1996 Feb;148(2):509-17.

20.

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.

Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE, Black R.

Science. 1995 Nov 17;270(5239):1197-9.

PMID:
7502044
21.

Human immunodeficiency virus.

Arthur LO, Henderson LE, Benveniste RE.

N Engl J Med. 1995 Jun 22;332(25):1719. No abstract available.

PMID:
7760882
22.

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

Arthur LO, Bess JW Jr, Urban RG, Strominger JL, Morton WR, Mann DL, Henderson LE, Benveniste RE.

J Virol. 1995 May;69(5):3117-24.

24.

Characterization of infectious type D retrovirus from baboons.

Grant RF, Windsor SK, Malinak CJ, Bartz CR, Sabo A, Benveniste RE, Tsai CC.

Virology. 1995 Feb 20;207(1):292-6.

25.

Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Ward JM, Anver MR, Haines DC, Benveniste RE.

Am J Pathol. 1994 Oct;145(4):959-68.

26.

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.

Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, Morton WR, Shearer GM, Benveniste RE.

AIDS. 1994 Oct;8(10):1391-5.

PMID:
7818809
27.

Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS.

Kuller L, Benveniste RE, Tsai CC, Clark EA, Polacino P, Watanabe R, Overbaugh J, Katze MG, Morton WR.

J Med Primatol. 1994 Sep;23(7):397-409.

PMID:
7731030
28.

Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques.

Tsai CC, Follis KE, Sabo A, Grant RF, Bartz C, Nolte RE, Benveniste RE, Bischofberger N.

J Infect Dis. 1994 Feb;169(2):260-6.

PMID:
8106760
29.

Infectivity of titered doses of simian immunodeficiency virus clone E11S inoculated intravenously into rhesus macaques (Macaca mulatta).

Benveniste RE, Roodman ST, Hill RW, Knott WB, Ribas JL, Lewis MG, Eddy GA.

J Med Primatol. 1994 Feb-May;23(2-3):83-8.

PMID:
7966238
30.

Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.

Tsai CC, Follis KE, Grant RF, Nolte RE, Bartz CR, Benveniste RE, Sager PR.

J Acquir Immune Defic Syndr. 1993 Oct;6(10):1086-92.

PMID:
8410666
31.
32.

Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection.

Lewis MG, Elkins WR, McCutchan FE, Benveniste RE, Lai CY, Montefiori DC, Burke DS, Eddy GA, Shafferman A.

Vaccine. 1993 Oct;11(13):1347-55.

PMID:
7507625
33.

Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.

Hu SL, Stallard V, Abrams K, Barber GN, Kuller L, Langlois AJ, Morton WR, Benveniste RE.

J Med Primatol. 1993 Feb-May;22(2-3):92-9.

PMID:
8411113
34.
35.

Intra-amniotic inoculation of pigtailed macaque (Macaca nemestrina) fetuses with SIV and HIV-1.

Ochs HD, Morton WR, Kuller LD, Zhu Q, Tsai CC, Agy MB, Benveniste RE.

J Med Primatol. 1993 Feb-May;22(2-3):162-8.

PMID:
8411108
36.

Detection of serum antibodies in Ethiopian baboons that cross-react with SIV, HTLV-I, and type D retroviral antigens.

Benveniste RE, Hill RW, Knott WB, Tsai CC, Kuller L, Morton WR.

J Med Primatol. 1993 Feb-May;22(2-3):124-8.

PMID:
8411104
37.

Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge.

Shafferman A, Lewis MG, McCutchan FE, Benveniste RE, Jahrling PB, Burke DS, Eddy GA.

Vaccine. 1993;11(8):848-52.

PMID:
8356845
38.

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Arthur LO, Bess JW Jr, Sowder RC 2nd, Benveniste RE, Mann DL, Chermann JC, Henderson LE.

Science. 1992 Dec 18;258(5090):1935-8.

PMID:
1470916
39.

Transmission of SIVMne from female to male Macaca nemestrina.

Kuller L, Benveniste RE, Watanabe R, Tsai CC, Morton WR.

J Med Primatol. 1992 Aug;21(6):299-307.

PMID:
1297851
40.

Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission.

Shafferman A, Lewis MG, McCutchan FE, Benveniste RE, Jahrling PB, Hickman RL, Lai CY, Burke DS, Eddy GA.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1483-7. No abstract available.

PMID:
1281660
41.

Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.

Hu SL, Abrams K, Misher L, Stallard V, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.

J Med Primatol. 1992 Feb-May;21(2-3):119-25.

PMID:
1433262
42.

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

Hu SL, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.

Science. 1992 Jan 24;255(5043):456-9.

PMID:
1531159
43.

Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.

Overbaugh J, Rudensey LM, Papenhausen MD, Benveniste RE, Morton WR.

J Virol. 1991 Dec;65(12):7025-31.

44.

Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences.

Shafferman A, Jahrling PB, Benveniste RE, Lewis MG, Phipps TJ, Eden-McCutchan F, Sadoff J, Eddy GA, Burke DS.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7126-30.

45.

Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne.

Agy MB, Foy K, Gale MJ, Benveniste RE, Clark EA, Katze MG.

Virology. 1991 Jul;183(1):170-80.

PMID:
1675822
46.

Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection.

Ochs HD, Morton WR, Tsai CC, Thouless ME, Zhu Q, Kuller LD, Wu YP, Benveniste RE.

J Med Primatol. 1991 Jun;20(4):193-200.

PMID:
1658326
47.

In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV).

Tsai CC, Follis KE, Yarnall M, Deaver LE, Benveniste RE, Sager PR.

Antiviral Res. 1990 Aug;14(2):87-98.

PMID:
1703397
48.

Simian immunodeficiency virus is restricted to a subset of blood CD4+ lymphocytes that includes memory cells.

Willerford DM, Gale MJ Jr, Benveniste RE, Clark EA, Gallatin WM.

J Immunol. 1990 May 15;144(10):3779-83.

PMID:
1970593
49.

Evidence that HIV-1 gag precursor shares antigenic sites with the major capsid protein of human cytomegalovirus.

Gibson W, McNally LM, Benveniste RE, Ward JM.

Virology. 1990 Apr;175(2):595-9.

PMID:
1691565
50.

CD4 and CD8 T cells from SIV-infected macaques have defective signaling responses after perturbation of either CD3 or CD2 receptors.

Gale MJ Jr, Ledbetter JA, Schieven GL, Jonker M, Morton WR, Benveniste RE, Clark EA.

Int Immunol. 1990;2(9):849-58.

PMID:
1980619

Supplemental Content

Loading ...
Support Center